<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Exclusive: AI startup Chai lands GSK deal, its sixth pharma partner in nine months — Live Feed</title><link>https://www.live-feeds.com/feed/exclusive-ai-startup-chai-lands-gsk-deal-its-sixth-pharma-partner-in-nine-months</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/exclusive-ai-startup-chai-lands-gsk-deal-its-sixth-pharma-partner-in-nine-months/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>AI startup Chai secures GSK partnership for biological models</title><link>https://www.live-feeds.com/feed/exclusive-ai-startup-chai-lands-gsk-deal-its-sixth-pharma-partner-in-nine-months</link><guid isPermaLink="false">https://www.live-feeds.com/feed/exclusive-ai-startup-chai-lands-gsk-deal-its-sixth-pharma-partner-in-nine-months#u118428</guid><pubDate>Mon, 12 Oct 2026 14:43:05 +0000</pubDate><description>Artificial intelligence startup Chai Discovery has signed a collaboration agreement with GSK, making the drugmaker its sixth pharmaceutical partner in nine months. The partnership follows a successful wet-lab evaluation of Chai Discovery&amp;#039;s AI models. The startup focuses on developing advanced technology for biological discovery and drug development. Pharmaceutical companies increasingly turn to artificial intelligence tools to accelerate research and development pipelines. This deal expands the startup&amp;#039;s industry footprint as major drugmakers test computational biology applications a</description></item>
</channel></rss>